Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer

Hepato-Gastroenterology

Volumn 54, Issue 76, 2007, Pages 1272-1275

  Goral, Vedat ^a   Yesilbagdan, Haluk ^a   Kaplan, Abdurahman ^a   Sit, Dede ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

CA 72 4 level; Gastric cancer

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 34347338841     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chan AO, Wong BC, Lam SK: Gastric cancer: Past, present and future. Can J Gastroenterol 2001; 15:469-474.
2. Asghar RJ, Parsonnet J: Helicobacter pylori and risk for gastric adenocarcinoma. Semin Gastrointest Dis 2001; 12:203-208.
3. Aloe S, D Alessandro R, Spila A, Feroni P, et al: Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer. Int J Biol Markers 2003; 18(1):21-27.
4. McCulloch P: Gastric cancer. Postgrad Med J 1996; 72:450-455.
5. Steplexski Z, Chang TH, Herlyn M, Koprowski H: Release of monoclonal antibody-defined antigens by human carcinoma and melanoma cells. Cancer Res 1981; 41:2723-2727.
6. Mcintire RK: Tumor markers; How useful are they? Hosp Pract 1984; 11:55.
7. Reiter W, Stieber P, Reuter C, et al: Prognostic value of preoperative serum levels of CEA, CA 19-9, CA 72-4 in gastric carcinoma. Anticancer Res 1997; 17(4B):2903-2906.
8. Pacelli F, Doglietto GB, Alfieri S, et al: Survival in early gastric cancer: Multivariate analysis on 72 consecutive cases. Hepatogastroenterology 1999; 46:1223-1228.
9. Marrelli D, Roviello F, Stefano AD, Farnetani M, Garosi L, Messano A, Pinto E: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57:55-66.
10. Joypaul B, Browning M, Newman E, et al: Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995; 169(6):595-599.
11. Staab HJ, Andereas FA, Brumendorf T, et al: Prognostic value of preoperative serum CEA levels compared to clinical stage. Br J Cancer 1982; 45:718-724.
12. Byrne DJ, Browning MC, Cuschieri A: CA 72-4: a new tumour marker for gastric cancer. Br J Surg 1990; 77(9):1010-1013.
13. Marelli D, Roviello F, De Stefano A, et al: Prognostic significance of CEA, CA 19-9, CA 72-4. Oncology 1999; 57(1):55-62.
14. Marrelli D, Roviello F, Stefano AD, Farnetani M, Garosi L, Messano A, Pinto E: Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57:55-66.
15. Ikeda Y, Oomori H, Koyanagi N, Mori M, Kamakura T, Minagawa S, Tateishi H, Sugimachi K: Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer. Oncology 1995; 52(6):483-486.
16. Ishigami S, Natsugoe S, Shuuichi H, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T: Clinical importance of preoperative CEA and CA 19-9 levels in gastric cancer.J Clin Gastroenterol 2001; 32:41-44.
17. Joypaul B, Browning M, Newman E: Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995; 169(6):595-599.
18. Heptner G, Domschke S, Domschke W: Comparison of CA 72-4 with CA 19-9 and CEA in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989; 24:745-750.
19. Kodama I, Koufuji K, Kawabata S, et al: The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA 19-9 and CEA. Int Surg 1995; 80(1):45-48.
20. Ubukata H, Katano M, Mothashi G, Kasuga T, Takemura B, Tabuchi T: Evaluation of CA72-4 as a tumor marker in patients with gastric cancer. Gan to kagaku Ryono 2003; (11):1821-1824.